Matthias Kromayer - Profile and Investment Details

Investor Profile

Matthias Kromayer is a Venture Capital, Private Equity Firm, Entrepreneurship Program based in Munich, Bavaria, Germany with a diverse investment portfolio that includes companies such as Siltectra, Hemovent, AFFiRiS, KEWAZO, Corimmun, GWA Hygiene, immatics biotechnologies, BioNTech, IDENT Technology, Protagen, Sovicell GmbH, Biocrates Life Sciences, NavVis, Second Closet, advanceCOR, Isarna Therapeutics, Ganymed Pharmaceuticals, Liva Healthcare, NFON, KONUX, AMSilk, German Bionic, LXP Group GmbH, SuppreMol, IQM, PDC Biotech, Efficient Energy, Innatera Nanosystems, Cynora. Over time, Matthias Kromayer has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Matthias Kromayer is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Commercial, Wearables, Customer Service, Wellness, Medical Testing, GreenTech, Gyms, Transportation, Apps, Energy, Industrial Automation, Chemical, Life Science, Lighting, Artificial Intelligence (AI), Robotics, Product Design, Analytics, Social Entrepreneurship, Factory Tech, Manufacturing, Biotechnology, Construction, Computers, Energy Efficiency, Open Source, Clean Technology, Warehousing, Hardware, Health Diagnostics, Environmental Engineering, Fitness, mHealth, Media and Entertainment, Quantum Computing may find it worthwhile to explore potential connections with Matthias Kromayer, as their portfolio suggests a familiarity and interest in this area.

Understanding Matthias Kromayer’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.